Skip to main content
. 2015 Nov 2;7(3):2910–2920. doi: 10.18632/oncotarget.6272

Figure 4. Glucose-6-phosphate dehydrogenase inhibition with siRNA reduces proliferation of glycolytic cancer cells.

Figure 4

MDA-MB-231 cancer cells were transfected with siRNAs targeting G6PD (siG6PD) or non-targeting siRNAs (siCTL). 48 hours after transfection, cells were subjected to A. immunoblot analysis using Hsp90 as loading control, B. NADP+ and NADPH levels quantification and C. DNA synthesis measurement. Two-sided t test. *p < 0.05, ***p < 0.001. Results are expressed as means ± SEM.